FDA Drug Application (084617) for DRALSERP by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number084617
Product Number001
FormTABLET;ORAL
Dosage25MG;0.1MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDRALSERP
Active IngredientHYDRALAZINE HYDROCHLORIDE; RESERPINE



Back to FDA Applications sponsored by SANDOZ

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.